Credit NIAID
#18,967
In May of 2024 we looked at plan by Japan's MOH To Stockpile 10 Million Doses of H5N1 Vaccine, enough to vaccinate about about 8% of their population.
Over the past 2 decades more than 4 dozen H5Nx candidate vaccine viruses (CVVs) have been selected by WHO for development.
In a follow-up report last April (see Japan: Updated HPAI H5 Risk Assessment & Pre-pandemic Vaccine Selection), we looked at Japan's decision to go with a locally detected H5N1 virus; a strain isolated from an infected fox with viral meningoencephalitis collected on Hokkaido in 2022.
Today's report, however, finds that even though lacking these `red flag' mutations - this isolate produced high virulence and robust replication in mice - suggesting other gene factors may drive pathogenicity.What makes this choice interesting is this isolate did not carry the amino acid markers (PB2-E627K or PB2-D701N) that we typically associate with increased virulence and replication in mammals.
While the murine model has known limitations in influenza research, it can be useful; particularly in virulence studies (see Animal Models for Influenza Research: Strengths and Weaknesses).
First, a link and some excerpts from the study, after which I'll return with a postscript.
Characterization of H5N1 high pathogenicity avian influenza virus belonging to clade 2.3.4.4b isolated from Ezo red fox in Japan in a mouse model
Authors: Shintaro Shichinohe Takahiro Hiono, Yasushi Itoh , Kosuke Takada, Yurie Kida, Pei Wang, Daisuke Motooka, Norikazu Isoda, Ayato Takada, Yoshihiro Sakoda , Tokiko Watanabe tokikow@biken.osaka-u.ac.jpAuthors Info & Affiliations
https://doi.org/10.1128/spectrum.01097-25
PDF/EPUB
ABSTRACT
H5N1 high pathogenicity avian influenza virus (HPAIV) has spread in wild birds and poultry worldwide. H5N1 HPAIV belonging to the currently predominant clade 2.3.4.4b has infected not only birds but also mammals (wild and domestic animals), with several human infections also being reported, raising concerns for public health.In 2022, a clade 2.3.4.4b H5N1 HPAIV strain, A/Ezo red fox/Hokkaido/1/2022 (H5N1; Fox/Hok/1/22), was isolated from an Ezo red fox (Vulpes vulpes schrencki) in Hokkaido, Japan; this was the first reported case of clade 2.3.4.4b H5N1 HPAIV isolation from a mammalian species in Japan. Several amino acid substitutions in the PB2 protein play an important role in the adaptation of avian influenza viruses to mammals, but Fox/Hok/1/22 PB2 does not have any of these well-known mammalian-adapting PB2 substitutions.Here, we investigated the biological properties of Fox/Hok/1/22 in a mouse model and found that this virus was highly virulent in mice and replicated well in multiple organs, including the lungs and brain. We then examined whether viruses isolated from these organs acquired known mammalian-adapting PB2 amino acid substitutions, such as PB2 E627K.Deep sequencing analysis of viral RNA from mouse brain and lungs revealed that virus with PB2-627E was predominant in three of four mice, whereas the PB2-627K substitution was predominant in one mouse. These results indicate that Fox/Hok/1/22 is highly virulent in mice despite lacking known PB2 substitutions involved in mammalian adaptation.
IMPORTANCE
The H5N1 avian influenza virus has caused severe disease in birds worldwide and is now spreading to mammals, including humans. In 2022, this virus was detected for the first time in an Ezo red fox in Japan. To understand its potential impact on mammals, we studied this virus in mice and found that it caused severe illness, spreading to multiple organs, including the lungs and brain.Surprisingly, despite lacking genetic mutations typically associated with mammalian adaptation, the virus was highly virulent in mice.
This finding suggests that the H5N1 virus may pose a greater threat to mammals, including humans, than previously thought. Given their continued spread among wild and domestic animals, our findings underscore the urgent need to monitor how recent H5N1 viruses behave in mammals.
(SNIP)
DISCUSSION
Clade 2.3.4.4b H5N1 HPAIV has caused tremendous damage worldwide, especially in poultry and wild birds, as well as many cases of infection in mammals, including carnivores, such as red foxes, in Asia, Europe, and the USA (1). It has been reported that foxes can be infected with H5N1 HPAIV by feeding on HPAIV-infected birds (14).
Previously, Hiono et al. isolated clade 2.3.4.4b H5N1 HPAIV (Fox/Hok/1/22) from a dead Ezo red fox in Hokkaido, Japan (10). This was the first clade 2.3.4.4b H5N1 HPAIV isolation from a mammal in Japan. Phylogenetic similarity between virus isolated from the fox and that from birds suggests that infection can be caused by fox predation on virus-infected birds (15).
Here, we investigated the biological properties of Fox/Hok/1/22 in a mammalian model. We found that the MLD50 of Fox/Hok/1/22 was 100.5 PFU, and that Fox/Hok/1/22, like other H5N1 HPAIVs, grew in multiple organs, including the brain and respiratory tract of the virus-infected mice (Table 1). These results indicate that Fox/Hok/1/22 efficiently replicates and is highly virulent in the mouse model.
(SNIP)
Although efficient transmission among humans has not yet occurred, further outbreaks in various wild mammals should be carefully monitored, and proactive measures should be taken to prevent and treat infections with these viruses.
This isn't the first time we've seen evidence that HPAI H5N1 can be virulent in mammals without these notorious PB2 mutations. Eleven months ago, the CDC published Genetic Sequences of Highly Pathogenic Avian Influenza A(H5N1) Viruses Identified in a Person in Louisiana (who later died), which found:
The genetic sequences of the A(H5N1) viruses from the patient in Louisiana did not have the PB2 E627K change or other changes in polymerase genes associated with adaptation to mammals and no evidence of low frequency changes at critical positions.
And, like other D1.1 genotype viruses found in birds, the sequences lack PB2 M631L, which is associated with viral adaptation to mammalian hosts, and which has been detected in >99% of dairy cow sequences but is only sporadically found in birds.
Interestingly, the CDC also noted that the HA of this Louisiana isolate was closely aligned with the Ezo fox isolate discussed above.
Overall, the hemagglutinin (HA) sequences from the two clinical specimens were closely related to HA sequences detected in other D1.1 genotype viruses, including viruses sequenced from samples collected in November and December 2024 in wild birds and poultry in Louisiana. The HA genes of these viruses also were closely related to the A/Ezo red fox/Hokkaido/1/2022 candidate vaccine virus (CVV) with 2 or 3 amino acid changes detected.
These reports complicate matters, because they suggest we can't automatically assume that just because an HPAI virus doesn't carry these PB2 mutations, that it is guaranteed to be less of a public health threat.